Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are introduced.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Latest history entry adds Contacts/Locations and Study Status to the study record. A deletion was recorded on 2025-09-16.
    Difference
    0.3%
    Check dated 2026-03-04T11:36:39.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.4.2' to the version history. Removed the government funding lapse notice; these changes do not affect the study record content.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center’s open status, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:58:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option and explain color-coding for additions/deletions (green/red), and the page revision label shifts from v3.3.4 to v3.4.0 with capitalization tweaks in 'No FEAR Act data'.
    Difference
    0.5%
    Check dated 2026-01-28T03:14:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:37.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.